{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T23:15:23Z","timestamp":1794093323459,"version":"4.8.0"},"reference-count":9,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,15]]},"DOI":"10.1182\/blood.2026035515","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:31:50Z","timestamp":1792078310000},"page":"1947-1948","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Neurotoxicity with CAR T cells in myeloma deciphered?"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0405-1676","authenticated-orcid":false,"given":"Monika","family":"Engelhardt","sequence":"first","affiliation":[{"name":"University of Freiburg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0813-3444","authenticated-orcid":false,"given":"Ralph","family":"W\u00e4sch","sequence":"additional","affiliation":[{"name":"University of Freiburg"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"16","key":"2026101511314349800_bib1","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood.2025032844","article-title":"Rapid peak cilta-cel expansion is associated with delayed neurotoxicity in multiple myeloma","volume":"148","author":"Hosoya","year":"2026","journal-title":"Blood"},{"issue":"25","key":"2026101511314349800_bib2","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1200\/JCO-25-00760","article-title":"Long-term (\u22655-year) remission and survival after treatment with ciltacabtagene autoleucel in CARTITUDE-1 patients with relapsed\/refractory multiple myeloma","volume":"43","author":"Jagannath","year":"2025","journal-title":"J Clin Oncol"},{"issue":"10","key":"2026101511314349800_bib3","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1182\/bloodadvances.2025018639","article-title":"Dexamethasone prophylaxis for excessive lymphocyte expansion after cilta-cel in multiple myeloma","volume":"10","author":"Forsberg","year":"2026","journal-title":"Blood Adv"},{"issue":"1","key":"2026101511314349800_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41408-025-01441-3","article-title":"Clinical course, risk factors and mitigating strategies for immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma","volume":"16","author":"Lim","year":"2025","journal-title":"Blood Cancer J"},{"issue":"8","key":"2026101511314349800_bib5","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/s43018-024-00764-7","article-title":"Targeting TGF\u03b2-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome","volume":"5","author":"Vinnakota","year":"2024","journal-title":"Nat Cancer"},{"issue":"8","key":"2026101511314349800_bib6","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.3324\/haematol.2023.283058","article-title":"Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible","volume":"109","author":"Engelhardt","year":"2024","journal-title":"Haematologica"},{"issue":"1","key":"2026101511314349800_bib7","first-page":"593","article-title":"Optimizing individualized therapy decision-making in multiple myeloma (MM): integration and impact of the Revised Myeloma Comorbidity Index in the MM-tumor board","volume":"104","author":"Dreyling","year":"2025","journal-title":"Ann Hematol"},{"issue":"2","key":"2026101511314349800_bib8","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1016\/j.clml.2020.10.002","article-title":"Real-world evaluation of health-related quality of life in patients with multiple myeloma from Germany","volume":"21","author":"Engelhardt","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"2026101511314349800_bib9","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/S1470-2045(24)00715-0","article-title":"Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee","volume":"26","author":"Graham","year":"2025","journal-title":"Lancet Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/16\/1947\/2594919\/blood_bld-2026-035515-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/16\/1947\/2594919\/blood_bld-2026-035515-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:31:51Z","timestamp":1792078311000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/16\/1947\/571438\/Neurotoxicity-with-CAR-T-cells-in-myeloma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":9,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2026,10,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2026035515","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,15]]},"published":{"date-parts":[[2026,10,15]]}}}